Puma Biotechnology, Inc. is a biopharmaceutical company dedicated to the global development and commercialization of treatments aimed at advancing cancer care.
52W Range
91stpctl
Volume
0.77×avg
Market Cap
461.15MUSD
P/E Ratio
16.9TTM
Div Yield
-ann
Loading chart data...
Current StateState loading
Puma Biotechnology, Inc.
PBYINASDAQ Global Select·USD·Closed
Puma Biotechnology, Inc.
PBYINASDAQ·USD·Closed
$9.06
−1.95%
$9.06
−$0.18 (1.95%)
52W Range
91stpctl
Volume
0.77×avg
Mkt Cap
461.15MUSD
P/E
16.9TTM
Div Yield
–ann
PBYI: Puma Biotechnology, Inc. Stock Analysis | finqOS
